BIOTECHPHARMA BIOTECHNOLOGINES FARMACIJOS CENTRAS UAB

FDA inspection history in Vilnius, Lithuania, 2024

1
Form 483

Every document, by year

  • Form 483

2024: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2024One Form 483, at Vilnius, Lithuania.

Cited most

Across all BIOTECHPHARMA BIOTECHNOLOGINES FARMACIJOS CENTRAS UAB observations on file

The complete BIOTECHPHARMA BIOTECHNOLOGINES FARMACIJOS CENTRAS UAB file.

All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.

$99

The documents one by one, while the file is prepared

See the documents

Sites

Documents

1 on file, newest first
DateDocumentPrice
2024-01-31483 Form 483$99

FEI number 3013580461 · most recent document Jan 31, 2024

About BIOTECHPHARMA BIOTECHNOLOGINES FARMACIJOS CENTRAS UAB

How many FDA Form 483s has BIOTECHPHARMA BIOTECHNOLOGINES FARMACIJOS CENTRAS UAB received?

FDA Intel has 1 Form 483 on file for BIOTECHPHARMA BIOTECHNOLOGINES FARMACIJOS CENTRAS UAB; the most recent is dated Jan 31, 2024.

When was BIOTECHPHARMA BIOTECHNOLOGINES FARMACIJOS CENTRAS UAB last inspected by FDA?

The most recent FDA inspection document on file for BIOTECHPHARMA BIOTECHNOLOGINES FARMACIJOS CENTRAS UAB is a Form 483 dated Jan 31, 2024, for the site in Vilnius, Lithuania.

What did FDA cite at BIOTECHPHARMA BIOTECHNOLOGINES FARMACIJOS CENTRAS UAB?

The regulations cited most in the observations on file for BIOTECHPHARMA BIOTECHNOLOGINES FARMACIJOS CENTRAS UAB are 21 CFR 211.160 (General requirements), 2 times; 21 CFR 211.192 (Production record review), 2 times; 21 CFR 211.42 (Design and construction features), 2 times.